192 related articles for article (PubMed ID: 6402034)
41. Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.
Scharenberg JG; Rijkers GT; Spaapen LJ; Toebes EA; Rijksen G; Duran M; Staal GE; Zegers BJ
Int J Immunopharmacol; 1988; 10(6):675-86. PubMed ID: 2974022
[TBL] [Abstract][Full Text] [Related]
42. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
Thompson LF; Willis RC; Stoop JW; Seegmiller JE
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
[TBL] [Abstract][Full Text] [Related]
43. The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro.
Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Duran M; Stoop JW; Zegers BJ
J Immunol; 1984 May; 132(5):2318-23. PubMed ID: 6425400
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.
Pérignon JL; Bories DM; Houllier AM; Thuillier L; Cartier PH
Biochim Biophys Acta; 1987 Apr; 928(2):130-6. PubMed ID: 3567226
[TBL] [Abstract][Full Text] [Related]
45. Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T-cell immunodeficiency.
Burke WG; Chen SH; Scott CR; Ammann AJ
J Cell Physiol; 1977 Jul; 92(1):109-13. PubMed ID: 408357
[TBL] [Abstract][Full Text] [Related]
46. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
Gregus Z; Németi B
Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
[TBL] [Abstract][Full Text] [Related]
47. Lymphocyte maturation in the human thymus. Relevance of purine nucleotide metabolism for intrathymic T cell function.
Schuurman HJ; van Laarhoven JP; Broekhuizen R; Spierenburg GT; Brekelmans P; Figdor CG; de Bruyn CH; Kater L
Scand J Immunol; 1983 Dec; 18(6):539-49. PubMed ID: 6420881
[TBL] [Abstract][Full Text] [Related]
48. Metabolism of hypoxanthine in isolated rat hepatocytes.
Vincent MF; Van den Berghe G; Hers HG
Biochem J; 1984 Aug; 222(1):145-55. PubMed ID: 6206848
[TBL] [Abstract][Full Text] [Related]
49. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
50. Purine nucleoside phosphorylase. Microheterogeneity and comparison of kinetic behavior of the enzyme from several tissues and species.
Agarwal KC; Agarwal RP; Stoeckler JD; Parks RE
Biochemistry; 1975 Jan; 14(1):79-84. PubMed ID: 1109594
[TBL] [Abstract][Full Text] [Related]
51. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts.
Snyder FF; Trafzer RJ; Hershfield MS; Seegmiller JE
Biochim Biophys Acta; 1980 Oct; 609(3):492-501. PubMed ID: 6108130
[TBL] [Abstract][Full Text] [Related]
52. Profiles of purine metabolism in leaves and roots of Camellia sinensis seedlings.
Deng WW; Ashihara H
Plant Cell Physiol; 2010 Dec; 51(12):2105-18. PubMed ID: 21071429
[TBL] [Abstract][Full Text] [Related]
53. Enzymes of purine metabolism in Mycoplasma mycoides subsp. mycoides.
Mitchell A; Sin IL; Finch LR
J Bacteriol; 1978 Jun; 134(3):706-12. PubMed ID: 207675
[TBL] [Abstract][Full Text] [Related]
54. Effects of 5-mercapto-2'-deoxyuridine on the incorporation of nucleosides into RNA and DNA in a primary lymphocyte culture system.
Bogyo D; Bardos TJ; Chmielewicz ZF
Cancer Res; 1976 Sep; 36(9 pt.1):3284-93. PubMed ID: 975090
[TBL] [Abstract][Full Text] [Related]
55. 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.
Sidi Y; Mitchell BS
J Clin Invest; 1984 Nov; 74(5):1640-8. PubMed ID: 6334099
[TBL] [Abstract][Full Text] [Related]
56. Genetic deficiency of purine nucleoside phosphorylase in the mouse. Characterization of partially and severely enzyme deficient mutants.
Mably ER; Fung E; Snyder FF
Genome; 1989 Dec; 32(6):1026-32. PubMed ID: 2516826
[TBL] [Abstract][Full Text] [Related]
57. Role of salvage and phosphorylation in the immunostimulatory activity of C8-substituted guanine ribonucleosides.
Goodman MG
J Immunol; 1988 Oct; 141(7):2394-9. PubMed ID: 2459208
[TBL] [Abstract][Full Text] [Related]
58. Purine nucleoside kinases in human T- and B-lymphoblasts.
Yamada Y; Goto H; Ogasawara N
Biochim Biophys Acta; 1983 Nov; 761(1):34-40. PubMed ID: 6315069
[TBL] [Abstract][Full Text] [Related]
59. A rat model of purine nucleoside phosphorylase deficiency.
Osborne WR; Barton RW
Immunology; 1986 Sep; 59(1):63-7. PubMed ID: 3019875
[TBL] [Abstract][Full Text] [Related]
60. Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.
Gilbertsen RB; Josyula U; Sircar JC; Dong MK; Wu WS; Wilburn DJ; Conroy MC
Biochem Pharmacol; 1992 Sep; 44(5):996-9. PubMed ID: 1530667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
